Standard of Care in Hormone Receptor-Positive Metastatic Breast Cancer: Can We Improve the Current Regimens or Develop Better Selection Tools?
JCO Oncol Pract
.
2022 May;18(5):331-334.
doi: 10.1200/OP.21.00707.
Epub 2021 Nov 15.
Authors
Paolo D'Amico
1
,
Massimo Cristofanilli
1
Affiliation
1
Department of Medicine-Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL.
PMID:
34780297
DOI:
10.1200/OP.21.00707
No abstract available
Publication types
Comment
MeSH terms
Breast Neoplasms* / pathology
Breast Neoplasms* / therapy
Female
Humans
Standard of Care